Death receptor 5 targeting activity-guided isolation of isoflavones from Millettia brandisiana and Ardisia colorata and evaluation of ability to induce TRAIL-mediated apoptosis

Bioorganic and Medicinal Chemistry

Volumn 17, Issue 3, 2009, Pages 1181-1186

  Kikuchi, Hiroyuki ^a   Ohtsuki, Takashi ^a   Koyano, Takashi ^b   Kowithayakorn, Thaworn ^c   Sakai, Toshiyuki ^d   Ishibashi, Masami ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Temko Corporation   (Japan)

^c KHON KAEN UNIVERSITY   (Thailand)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Apoptosis; DR5; Isoflavone; TRAIL resistance

Indexed keywords

ARDISIA COLORATA EXTRACT; BETA ACTIN; CASPASE 3; CASPASE 7; CASPASE 8; COLORATANIN A; DEATH RECEPTOR 5; FC RECEPTOR; ISOFLAVONE DERIVATIVE; MESSENGER RNA; MILLETTIA BRANDISIANA EXTRACT; PLANT EXTRACT; RECOMBINANT RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BARK; BIOASSAY; CARBON NUCLEAR MAGNETIC RESONANCE; CHIMERA; CONTROLLED STUDY; DRUG ISOLATION; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG TARGETING; FRACTIONATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; NONHUMAN; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; RECEPTOR UPREGULATION; STRUCTURE ACTIVITY RELATION;

APOPTOSIS; ARDISIA; CELL LINE, TUMOR; HUMANS; ISOFLAVONES; MILLETTIA; PLANT BARK; PLANT LEAVES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECOMBINANT FUSION PROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UP-REGULATION;

ARDISIA; MILLETTIA;

EID: 58949101425     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.12.033     Document Type: Article

References (37)

1. Ishibashi M., and Ohtsuki T. Med. Res. Rev. 28 (2008) 688
2. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., Smith C.A., and Goodwin R.G. Immunity 3 (1995) 673
3. Pitti R.M., Marsters S.A., Ruppert S., Donahue C.J., Moore A., and Ashkenazi A. J. Biol. Chem. 271 (1996) 12687
4. Walczak H., Miller R.E., Ariail K., Gliniak B., Griffith T.S., Kubin M., Chin W., Jones J., Woodward A., Le T., Smith C., Smolak P., Goodwin R.G., Rauch C.T., Schuh J.C., and Lynch D.H. Nat. Med. 5 (1999) 157
5. Ashkenazi A., Pai R.C., Fong S., Leung S., Lawrence D.A., Marsters S.A., Blackie C., Chang L., McMurtrey A.E., Hebert A., DeForge L., Koumenis I.L., Lewis D., Harris L., Bussiere J., Koeppen H., Shahrokh Z., and Schwall R.H. J. Clin. Invest. 104 (1999) 155
6. LeBlanc H.N., and Ashkenazi A. Cell Death Differ. 10 (2003) 66
7. Zhang L., and Fang B. Cancer Gene Ther. 12 (2005) 228
8. Lee T., Lee J., Park J., and Kwon T. Biochem. Biophys. Res. Commun. 351 (2006) 1024
9. Liu X., Yue P., Chen S., Hu L., Lonial S., Khuri F., and Sun S. Cancer Res. 67 (2007) 4981
10. Shiraishi T., Yoshida T., Nakata S., Horinaka M., Wakada M., Mizutani Y., Miki T., and Sakai T. Cancer Res. 65 (2005) 6364
11. Jung E.M., Lim J.H., Lee T.J., Park J.W., Choi K.S., and Kwon T.K. Carcinogenesis 26 (2005) 1905
12. Kim Y., Park J., Lee J., and Kwon T. Carcinogenesis 25 (2004) 1813
13. Son Y., Kim E., Kim J., Kim S., Kwon T., Yoon A., Yon C., and Choi K. Cancer Res. 67 (2007) 8274
14. Kikuchi H., Ohtsuki T., Koyano T., Kowithayakorn T., Sakai T., and Ishibashi M. J. Nat. Prod. 70 (2007) 1910
15. Kanchanapee P., Ogawa H., and Natori S. Shoyakugaku Zasshi 21 (1967) 68
16. Sumino M., Sekine T., Ruangrungsi N., and Ikegami F. Chem. Pharm. Bull. 49 (2001) 1664
17. Sumino M., Sekine T., Ruangrungsi N., Igarashi K., and Ikegami F. Chem. Pharm. Bull. 50 (2002) 1484
18. Shi H., Huang Z., Wen J., and Tu P. Zhonggu Tianran Yaowu 4 (2006) 30
19. Cocker W., Mcmurry T., and Staniland A. J. Chem. Soc. (1965) 1034
20. Krishnamurty H., and Prasad J. Phytochemistry 19 (1980) 2797
21. Sekine T., Inagaki M., Ikegami F., Fujii Y., and Ruangrungsi N. Phytochemistry 52 (1999) 87-94
22. Kinjo J., Furusawa J., Baba J., Takeshita T., Yamasaki M., and Nohara T. Chem. Pharm. Bull. 35 (1987) 4846
23. Tahara S., Katagiri Y., Ingham J., and Mizutani J. Phytochemistry 52 (1999) 87
24. Spencer G., Jones B., Plattner R., Barnekow D., Brinen L., and Clardy J. Phytochemistry 30 (1991) 4147
25. Guimaraes I., Gottlieb O., Andrade C., and Magalhaes T. Phytochemistry 14 (1975) 1452
26. Horinaka M., Yoshida T., Shiraishi T., Nakata S., Wakada M., Nakanishi R., Nishino H., Matsui H., and Sakai T. Oncogene 24 (2005) 7180
27. Horinaka M., Yoshida T., Shiraishi T., Nakata S., Wakada M., Nakanishi R., Nishino H., and Sakai T. Biochem. Biophys. Res. Commun. 333 (2005) 833
28. Jin C., Park C., Cheong J., Choi B., Lee T., Lee J., Lee W., Kim G., Ryu C., and Choi Y. Cancer Lett 257 (2007) 56
29. Srivastava R. Neoplasia 3 (2001) 535
30. Ichikawa K., Liu W., Zhao L., Wang Z., Liu D., Ohtsuka T., Zhang H., Mountz J., Koopman W., Kimberly R., and Zhou T. Nat. Med. 7 (2001) 954
31. Ohtsuka T., Buchsbaum D., Oliver P., Makhija S., Kimberly R., and Zhou T. Oncogene 22 (2003) 2034
32. Zhu H., Gou W., Zhang L., Wu S., Teraishi F., Davis J., Dong F., and Fang B. Cancer Biol. Ther 4 (2005) 781
33. Nakata S., Yoshida T., Shiraishi M., Horinaka M., Kouhara J., Wakada M., and Sakai T. Mol. Cancer Ther. 5 (2006) 1827
34. Ohtsuki T., Hiraka T., Kikuchi H., Koyano T., Kowithayakorn T., Sakai T., and Ishibashi M. Heterocycles 77 (2009) 1379
35. Yoshida T., Maeda A., Tani N., and Sakai T. FEBS Lett. 507 (2001) 381
36. Takimoto R., and EI-Deiry W. Oncogene 19 (2000) 1735
37. Ohtsuki T., Tamaki M., Toume K., and Ishibashi M. Bioorg. Med. Chem. 16 (2008) 1756